Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
ECBK vs NBTB vs CARE vs NECB vs MNSB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
ECBK vs NBTB vs CARE vs NECB vs MNSB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $178M | $2.44B | $686M | $356M | $176M |
| Revenue (TTM) | $80M | $902M | $252M | $156M | $135M |
| Net Income (TTM) | $8M | $169M | $31M | $44M | $16M |
| Gross Margin | 39.9% | 73.6% | 61.2% | 65.9% | 54.3% |
| Operating Margin | 13.1% | 24.3% | 15.9% | 39.8% | 14.1% |
| Forward P/E | 21.6x | 11.2x | 5.7x | 8.2x | 10.6x |
| Total Debt | $285M | $327M | $179M | $75M | $70M |
| Cash & Equiv. | $95M | $185M | $105M | $81M | $26M |
ECBK vs NBTB vs CARE vs NECB vs MNSB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 22 | Jun 26 | Return |
|---|---|---|---|
| ECB Bancorp, Inc. (ECBK) | 100 | 145.3 | +45.3% |
| NBT Bancorp Inc. (NBTB) | 100 | 115.1 | +15.1% |
| Carter Bankshares, … (CARE) | 100 | 221.9 | +121.9% |
| Northeast Community… (NECB) | 100 | 205.9 | +105.9% |
| MainStreet Bancshar… (MNSB) | 100 | 103.1 | +3.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ECBK vs NBTB vs CARE vs NECB vs MNSB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ECBK is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 16.5%, EPS growth 95.8%
- Lower volatility, beta 0.44, current ratio 0.10x
- 16.5% NII/revenue growth vs NECB's -1.6%
- Beta 0.44 vs NBTB's 0.73
NBTB is the clearest fit if your priority is defensive.
- Beta 0.73, yield 3.1%, current ratio 1.60x
CARE ranks third and is worth considering specifically for momentum.
- +86.8% vs NECB's +19.0%
NECB carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.65, yield 3.8%
- 485.8% 10Y total return vs CARE's 150.2%
- PEG 0.24 vs NBTB's 1.59
- NIM 4.9% vs ECBK's 2.0%
Among these 5 stocks, MNSB doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.5% NII/revenue growth vs NECB's -1.6% | |
| Value | Lower P/E (8.2x vs 11.2x), PEG 0.24 vs 1.59 | |
| Quality / Margins | Efficiency ratio 0.3% vs NBTB's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.44 vs NBTB's 0.73 | |
| Dividends | 3.8% yield, 2-year raise streak, vs NBTB's 3.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +86.8% vs NECB's +19.0% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs NBTB's 0.5% |
ECBK vs NBTB vs CARE vs NECB vs MNSB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ECBK vs NBTB vs CARE vs NECB vs MNSB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NECB leads in 3 of 6 categories
CARE leads 1 • ECBK leads 1 • NBTB leads 0 • MNSB leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NECB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $902M annually — 11.3x ECBK's $80M. NECB is the more profitable business, keeping 28.4% of every revenue dollar as net income compared to ECBK's 9.8%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $80M | $902M | $252M | $156M | $135M |
| EBITDAEarnings before interest/tax | $11M | $241M | $46M | $63M | $23M |
| Net IncomeAfter-tax profit | $8M | $169M | $31M | $44M | $16M |
| Free Cash FlowCash after capex | $9M | $225M | $30M | $51M | $11M |
| Gross MarginGross profit ÷ Revenue | +39.9% | +73.6% | +61.2% | +65.9% | +54.3% |
| Operating MarginEBIT ÷ Revenue | +13.1% | +24.3% | +15.9% | +39.8% | +14.1% |
| Net MarginNet income ÷ Revenue | +9.8% | +18.8% | +12.5% | +28.4% | +11.5% |
| FCF MarginFCF ÷ Revenue | +11.3% | +24.9% | +11.9% | +32.5% | +7.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +82.4% | +39.5% | +8.3% | +6.8% | +120.9% |
Valuation Metrics
NECB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 7.9x trailing earnings, NECB trades at a 64% valuation discount to CARE's 22.1x P/E. Adjusting for growth (PEG ratio), NECB offers better value at 0.23x vs NBTB's 1.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $178M | $2.4B | $686M | $356M | $176M |
| Enterprise ValueMkt cap + debt − cash | $368M | $2.6B | $759M | $350M | $219M |
| Trailing P/EPrice ÷ TTM EPS | 21.61x | 14.02x | 22.11x | 7.92x | 13.56x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 11.18x | 5.67x | 8.22x | 10.56x |
| PEG RatioP/E ÷ EPS growth rate | 1.16x | 1.99x | — | 0.23x | — |
| EV / EBITDAEnterprise value multiple | 35.47x | 10.70x | 18.98x | 5.52x | 11.48x |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 2.81x | 2.69x | 2.26x | 1.29x |
| Price / BookPrice ÷ Book value/share | 0.98x | 1.25x | 1.66x | 1.00x | 0.84x |
| Price / FCFMarket cap ÷ FCF | 19.80x | 11.13x | 21.57x | 7.00x | 16.52x |
Profitability & Efficiency
NECB leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
NECB delivers a 13.1% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $5 for ECBK. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to ECBK's 1.66x. On the Piotroski fundamental quality scale (0–9), CARE scores 8/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.6% | +9.5% | +7.6% | +13.1% | +7.3% |
| ROA (TTM)Return on assets | +0.5% | +1.1% | +0.7% | +2.2% | +0.7% |
| ROICReturn on invested capital | +1.8% | +7.9% | +5.7% | +12.5% | +5.0% |
| ROCEReturn on capital employed | +2.3% | +2.4% | +1.5% | +16.2% | +6.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 8 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.66x | 0.17x | 0.43x | 0.21x | 0.32x |
| Net DebtTotal debt minus cash | $190M | $142M | $73M | -$6M | $43M |
| Cash & Equiv.Liquid assets | $95M | $185M | $105M | $81M | $26M |
| Total DebtShort + long-term debt | $285M | $327M | $179M | $75M | $70M |
| Interest CoverageEBIT ÷ Interest expense | 0.22x | 1.05x | 0.39x | 1.17x | 0.31x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $23,985 today (with dividends reinvested), compared to $11,777 for MNSB. Over the past 12 months, CARE leads with a +86.8% total return vs NECB's +19.0%. The 3-year compound annual growth rate (CAGR) favors CARE at 26.8% vs MNSB's 2.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +17.3% | +14.0% | +59.9% | +14.8% | +21.1% |
| 1-Year ReturnPast 12 months | +34.3% | +20.5% | +86.8% | +19.0% | +33.1% |
| 3-Year ReturnCumulative with dividends | +55.6% | +49.9% | +103.8% | +93.0% | +8.4% |
| 5-Year ReturnCumulative with dividends | +44.1% | +46.9% | +139.8% | +138.3% | +17.8% |
| 10-Year ReturnCumulative with dividends | +44.1% | +103.1% | +150.2% | +485.8% | +126.0% |
| CAGR (3Y)Annualised 3-year return | +15.9% | +14.5% | +26.8% | +24.5% | +2.7% |
Risk & Volatility
ECBK leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ECBK is the less volatile stock with a 0.44 beta — it tends to amplify market swings less than NBTB's 0.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ECBK currently trades 99.1% from its 52-week high vs MNSB's 94.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.45x | 0.73x | 0.50x | 0.65x | 0.57x |
| 52-Week HighHighest price in past year | $20.50 | $48.81 | $31.40 | $26.14 | $25.19 |
| 52-Week LowLowest price in past year | $14.82 | $39.20 | $16.27 | $19.27 | $17.86 |
| % of 52W HighCurrent price vs 52-week peak | +99.1% | +95.6% | +98.6% | +98.5% | +94.7% |
| RSI (14)Momentum oscillator 0–100 | 59.4 | 51.0 | 76.8 | 58.5 | 50.3 |
| Avg Volume (50D)Average daily shares traded | 11K | 277K | 323K | 33K | 45K |
Analyst Outlook
Evenly matched — NBTB and NECB each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NBTB as "Hold", CARE as "Hold", NECB as "Hold", MNSB as "Hold". Consensus price targets imply -1.5% upside for NBTB (target: $46) vs -7.9% for CARE (target: $29). For income investors, NECB offers the higher dividend yield at 3.79% vs MNSB's 1.67%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | — | $46.00 | $28.50 | — | — |
| # AnalystsCovering analysts | — | 10 | 5 | 1 | 1 |
| Dividend YieldAnnual dividend ÷ price | — | +3.1% | — | +3.8% | +1.7% |
| Dividend StreakConsecutive years of raises | — | 13 | 0 | 2 | 0 |
| Dividend / ShareAnnual DPS | — | $1.43 | — | $0.98 | $0.40 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.6% | +0.4% | +2.9% | +0.4% | +2.5% |
NECB leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CARE leads in 1 (Total Returns). 1 tied.
ECBK vs NBTB vs CARE vs NECB vs MNSB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ECBK or NBTB or CARE or NECB or MNSB a better buy right now?
For growth investors, ECB Bancorp, Inc.
(ECBK) is the stronger pick with 16. 5% revenue growth year-over-year, versus -1. 6% for Northeast Community Bancorp, Inc. (NECB). Northeast Community Bancorp, Inc. (NECB) offers the better valuation at 7. 9x trailing P/E (8. 2x forward), making it the more compelling value choice. Analysts rate NBT Bancorp Inc. (NBTB) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ECBK or NBTB or CARE or NECB or MNSB?
On trailing P/E, Northeast Community Bancorp, Inc.
(NECB) is the cheapest at 7. 9x versus Carter Bankshares, Inc. at 22. 1x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 5. 7x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Northeast Community Bancorp, Inc. wins at 0. 24x versus NBT Bancorp Inc. 's 1. 59x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ECBK or NBTB or CARE or NECB or MNSB?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +139. 8%, compared to +17. 8% for MainStreet Bancshares, Inc. (MNSB). Over 10 years, the gap is even starker: NECB returned +485. 8% versus ECBK's +44. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ECBK or NBTB or CARE or NECB or MNSB?
By beta (market sensitivity over 5 years), ECB Bancorp, Inc.
(ECBK) is the lower-risk stock at 0. 45β versus NBT Bancorp Inc. 's 0. 73β — meaning NBTB is approximately 64% more volatile than ECBK relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 166% for ECB Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ECBK or NBTB or CARE or NECB or MNSB?
By revenue growth (latest reported year), ECB Bancorp, Inc.
(ECBK) is pulling ahead at 16. 5% versus -1. 6% for Northeast Community Bancorp, Inc. (NECB). On earnings-per-share growth, the picture is similar: MainStreet Bancshares, Inc. grew EPS 210. 0% year-over-year, compared to -7. 7% for Northeast Community Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ECBK or NBTB or CARE or NECB or MNSB?
Northeast Community Bancorp, Inc.
(NECB) is the more profitable company, earning 28. 2% net margin versus 9. 8% for ECB Bancorp, Inc. — meaning it keeps 28. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NECB leads at 39. 6% versus 13. 1% for ECBK. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ECBK or NBTB or CARE or NECB or MNSB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Northeast Community Bancorp, Inc. (NECB) is the more undervalued stock at a PEG of 0. 24x versus NBT Bancorp Inc. 's 1. 59x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 5. 7x forward P/E versus 11. 2x for NBT Bancorp Inc. — 5. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NBTB: -1. 5% to $46. 00.
08Which pays a better dividend — ECBK or NBTB or CARE or NECB or MNSB?
In this comparison, NECB (3.
8% yield), NBTB (3. 1% yield), MNSB (1. 7% yield) pay a dividend. ECBK, CARE do not pay a meaningful dividend and should not be held primarily for income.
09Is ECBK or NBTB or CARE or NECB or MNSB better for a retirement portfolio?
For long-horizon retirement investors, Northeast Community Bancorp, Inc.
(NECB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 65), 3. 8% yield, +485. 8% 10Y return). Both have compounded well over 10 years (NECB: +485. 8%, ECBK: +44. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ECBK and NBTB and CARE and NECB and MNSB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ECBK is a small-cap high-growth stock; NBTB is a small-cap deep-value stock; CARE is a small-cap quality compounder stock; NECB is a small-cap deep-value stock; MNSB is a small-cap deep-value stock. NBTB, NECB, MNSB pay a dividend while ECBK, CARE do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.